Search results
Results from the WOW.Com Content Network
For premium support please call: 800-290-4726
An analysis of three clinical trials published in February found that people who took aspirin for heart disease or stroke and then stopped taking the medication had a 28% higher risk of the ...
The proportion of patients using aspirin to reduce the risk of a secondary event varied by country, however, ranging from 16.6% in low-income countries such as Afghanistan, Benin and Ethiopia to ...
An analysis of multiple studies found a three-fold increase in adverse events such as myocardial infarction in patients who ceased aspirin prior to surgery. The analysis found that the risk is dependent on the type of surgery being performed and the patient indication for aspirin use. [221]
For patients taking blood-thinners, signs of severe bleeding should be monitored. The effect of aspirin can be life-threatening if taken over 150 mg/kg of body weight. [47] The medication should be discontinued at the first sign of excessive bleeding.
If the patient is 'low risk' using the CHA 2 DS 2-VASc score (that is, 0 in males or 1 in females), no anticoagulant therapy is recommended. In males with 1 stroke risk factor (that is, a CHA 2 DS 2-VASc score=1), antithrombotic therapy with OAC may be considered, and people's values and preferences should be considered. [24]
For some high-risk cardiovascular patients with stents, the often-recommended practice of prolonged taking of aspirin might be ineffective, and in some cases, even harmful, a new study found.
Therefore, patients with stents must take medications after the procedure to help maintain that blood flow. Ticlopidine, taken together with aspirin, is FDA approved for this purpose, and in studies it has been shown to work better than aspirin alone or aspirin with an anticoagulant.